Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Well considering all notes have been converted and the share structure hasn’t changed since 10q there has been no dilution at all…
When you take out a home equity line of credit does that mean that you have to use the line of credit? No…
It means you have a back up funding if needed to make sure you have all systems go for when FDA approval is officially received
No way to sugarcoat...it's dilution...the shares will be issued and JanBella LLC will be dumping those shares into the market.
It’s an equity line of credit secured by shares of RMSL. The filing is in fact not a public offering and no shares have been diluted as can be seen by the share structure updated on 6.10.22 (shares outstanding is same as it was on the 10q)
Actually looks like they entered into an equity line of credit back in May. Probably preparing to fund mask after approval.
They have several millions is cash so no need to take any cash cash from credit line at the moment.
Half a billion shares offering...dilution inbound:
http://archive.fast-edgar.com/20220615/AJ2ZM22CLW22F232222K22Y2C8HNZ222Y642/ea161575-s1_remsleep.htm
"Pre-revenue" is soft serve to the gullible. They pivoted from the DeltaWave being their flagship product to hawking third party cpap machines that are a dime a dozen on the internet.
They are going to need a lot of "positive cash flow" to crack that $10.7 million nut.
Pie-in-the-sky. Two guys and a CPAP is a delusional comp to a $30 billion annual revenue company.
A pre revenue company with almost no debt moving to positive cash flow and yet somebody still tries to say RMSL is in a bad spot because they issued new shares last year for an offering and notes being converted.
Do your own research people some people get paid if you interact with them
So are we going to skip over the Starbucks comparison? I mean pot calling kettle black…
RMSL's only 1/3 ish of the other steaming pile. What a convincing pump point.
So glad somebody brought up accumulated deficit compared to total shareholder equity. If you would like to know the total equity for WHSI is negative $1,853,344…. And if you are comparing just accumulated deficit and not total equity…. WHSI has negative $38,465,530 compared to RMSL negative $10,707,914 (keep in mind Rmsl was pre-revenue.)
But let’s look big picture since somebody brought up accumulated deficit being the value of a company…. Starbucks retained earnings (accumulated deficit) for 2021 was -$6.316 billion….
So which number do we use ??
Accounting/Balance Sheet 101...total equity doesn't mean jack because it's supposed to balance to the assets. Everything runs through Retained Earnings or in this case ACCUMULATED DEFICIT of $10.7 million.
There's a reason pumpers leave that one out.
Accumulated deficit is the bottom line book value of the company.
RMSL Financial Summary 1 Year Comparison
10Q Dated 3.31.22
Shares Outstanding 1,461,616,601 (368,063,606 shares from Debt Conversion)
Cash On Hand $4,014,578.00
Total Stock Holder Equity $3,697,160
Total Liabilities $510,347.00
One remaining convertible note payable for $86,350. (This note was converted in full on April 15, 2022.)
Loans Outstanding $67,140.00
Compensation expense $21,000 for the 3 month period
10Q Dated 3.31.21
Shares Outstanding 501,218,704
Cash On Hand $158,873.00
Total Stock Holder Deficit $723,916
Total Liabilities $1,004,039
Convertible Notes $152,277.00
Loans Outstanding $64,896.00
Compensation expense $21,000 for the 3 month period
New to this board ... just learned my little check marks show up as ? Mark... my bad
What we know about RMSL
?Patented Product
?FDA approval is on deck now
?Uplisting underway
?Inventory and sales
?increasing market cap
?warehouse expansion
?industry growth in multi $billion market
?potential buyout
?Highly experienced team
?No dilution of shares ??
Put all these pieces together and you have
a very unique opportunity that doesn’t
come along often! Buy and Hold
Thought no-one can talk about the "past"? What about that 70% price drop on the predicted delay I've been warning folks about?
Tom keeping his "promises" is a total joke.
SEC violations on timely material disclosure.
Forced Tom to clarify...happy to oblige.
No. That's not what I said. The DeltaWave is the only patent that has been ASSIGNED to Remsleep Holdings. You were implying by your statement that he has multiple patents so the 2015 8k could have been referring to any of them when that is NOT the case because there is only ONE that has been assigned to RMSL and that is the DELTAWAVE.
Yet again more misinformation from 2015… and now claiming remsleep doesn’t have rights to the patent.
You obviously don't understand how intellectual property ownership works.
Just because Tom owns several patents and is also the CEO doesn't automically give RMSL the rights to those patents. The patent has to be ASSIGNED to Remsleep Holdings, Inc. become an asset of RMSL.
The DeltaWave is the only patent that has been assigned by Tom to RMSL.
Nope. Right there in the 2015 8k which was solely about the launch of the DeltaWave:
https://www.sec.gov/Archives/edgar/data/1412126/000107878216004009/f8k122316_8k.htm
And yet here we are you asked for proof it was actually a second mask and they did just that…
Haha..nice deflection...the press release issued on June 6th didn't say ONE WORD about a second mask. It specified NASAL PILLOWS. Today's press release mentioned a second mask.
You do realize Tom has multiple different parents… ???????2015 I believe was for an entirely different device and not delta wave… but again keep living in the past…
April 2021 US 20 year patent officially received…
The patent was pending in 2017 and would have ZERO impact on Tom fulfilling the promise of delivering the DeltaWave in 2017. The 510k was supposedly in progress.
An offering has nothing to do with the promise Tom made of DeltaWave being delivered in 2017.
Oh and should I mention the pre-revenue to positive cash flow and profitable statement from todays PR…
Should we go back to the fact you still claimed there isn’t a second mask… or the fact that the price is still up 1200% since December 2020…
Well you are referencing from 2017… what changed is the patent received and funds needed to sell the Deltawave and go through 510k… and there was no offering even close to 2017 so again… Tom follows through even if there is delays.
You said Tom always follows through which the post shows to be false because he's been making empty promises for YEARS.
Take a look at the chart since December 2020… the trend doesn’t lie. Posting crap from 2017 when patent wasn’t even applied for shows how unintouch somebody is with reality
Maybe licensing the RIOII from 3B Medical that they had listed on the Remsleep website a while back:
https://3bproducts.com/masks/rio-ii-nasal-pillow/
Risky. Not a catalyst in sight.
Time to load up ??
Followers
|
309
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
31338
|
Created
|
11/14/08
|
Type
|
Free
|
Moderators |
REMSleep Holdings, Inc. is engaged in the business of developing and distributing sleep apnea products. The Company focuses on offering optimum compliance and comfort for continuous positive airway pressure (CPAP) patients. Its DeltaWave CPAP interface (the DeltaWave) is a device to treat patients with sleep apnea. Its DeltaWave product is a nasal-pillows type interface that is designed with airflow characteristics to enable patients with sleep apnea to breathe normally. Its product is manufactured by mold makers. Its target market includes home care dealers, private sleep labs, product end users, sleep physicians, medical groups, sleep product distributors, hospitals, medical associations, such as the American academy of sleep medicine and the American sleep association. REMSleep LLC is its wholly owned subsidiary.
INDUSTRY
Medical Equipment & Supplies
CONTACT INFO
2202 N. WEST SHORE BLVD SUITE 200
TAMPA, FL
33607
United States
+1.912.5902001
https://www.remsleep.com/EXECUTIVE LEADERSHIP
Russell Finlay Bird
Chairman of the Board
Thomas J. Wood
Chief Executive Officer, Director
Jonathan B Lane
Chief Technology Officer, Vice President
https://www.fundable.com/remsleep
Share Structure
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |